Lei Yao Selected Research

Drug Therapy (Chemotherapy)

4/2023	Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy.
2/2023	Thoracic perivascular adipose tissue inhibits VSMC apoptosis and aortic aneurysm formation in mice via the secretome of browning adipocytes.
1/2020	Recent Patents on the Development of c-Met Kinase Inhibitors.
1/2014	Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
1/2013	F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
8/2010	Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Yao Research Topics

Disease

64	Neoplasms (Cancer) 03/2024 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2010
14	Inflammation (Inflammations) 04/2024 - 01/2006
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2003
11	Glioma (Gliomas) 01/2019 - 11/2011
9	Infections 01/2024 - 06/2013
9	Neoplasm Metastasis (Metastasis) 11/2023 - 08/2011
6	Pain (Aches) 02/2024 - 01/2018
6	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 02/2013
6	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 03/2003
6	Fibrosis (Cirrhosis) 01/2023 - 07/2008
6	Myocardial Infarction 01/2023 - 10/2009
5	Reperfusion Injury 12/2023 - 04/2012
5	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2018
4	Cognitive Dysfunction 04/2024 - 01/2021
4	Heart Failure 01/2024 - 01/2018
4	Wounds and Injuries (Trauma) 01/2024 - 01/2021
4	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 01/2013
4	Vitiligo 11/2022 - 12/2012
4	Cholangiocarcinoma 01/2022 - 01/2015
4	Hypertension (High Blood Pressure) 01/2022 - 08/2010
4	Adenocarcinoma 01/2020 - 01/2011
4	Body Weight (Weight, Body) 12/2019 - 06/2009
4	Hemorrhage 12/2016 - 08/2011
4	Brain Neoplasms (Brain Tumor) 07/2016 - 01/2012
4	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 06/2013
4	Radiation Pneumonitis 12/2014 - 08/2010
3	Hypoxia (Hypoxemia) 05/2024 - 11/2021
3	Carcinogenesis 01/2023 - 01/2018
3	Obesity 01/2022 - 01/2018
3	Ischemia 01/2022 - 06/2009
3	Chronic Pain 10/2020 - 01/2018
2	Kidney Calculi (Kidney Stone) 12/2024 - 12/2016
2	Dyslipidemias (Dyslipidemia) 03/2024 - 09/2023
2	Tauopathies 02/2024 - 06/2023
2	Frailty 01/2024 - 01/2022
2	Weight Loss (Weight Reduction) 10/2023 - 01/2021
2	Asthma (Bronchial Asthma) 09/2023 - 01/2023
2	Abdominal Aortic Aneurysm 09/2023 - 02/2023
2	Adenocarcinoma of Lung 05/2023 - 01/2022
2	Postoperative Hemorrhage 05/2023 - 04/2023
2	Epilepsy (Aura) 05/2023 - 04/2022
2	Postoperative Pain 04/2023 - 10/2017
2	Mental Disorders (Mental Disorder) 02/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2011
14	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2013
12	ORALIT (ORS)IBA 01/2012 - 07/2010
9	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2010
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 11/2011
6	Volatile Oils (Essential Oils)IBA 04/2024 - 06/2013
6	Interleukin-6 (Interleukin 6)IBA 10/2023 - 12/2012
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
6	Peptides (Polypeptides)IBA 01/2014 - 01/2013
5	Long Noncoding RNAIBA 01/2022 - 01/2019
5	Circular RNAIBA 01/2022 - 01/2021
5	Therapeutic UsesIBA 12/2021 - 12/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 11/2004
5	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 03/2014 - 01/2013
4	CholesterolIBA 12/2024 - 10/2020
4	huoxue qianyangIBA 01/2022 - 12/2019
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 08/2019
4	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 01/2013
3	LipidsIBA 03/2024 - 07/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 11/2022
3	InflammasomesIBA 12/2023 - 10/2020
3	EnzymesIBA 02/2023 - 02/2010
3	Melanins (Melanin)IBA 01/2023 - 03/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 07/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 11/2007
3	Sirtuin 1IBA 01/2022 - 12/2019
3	CytokinesIBA 12/2021 - 12/2012
3	ChemokinesIBA 01/2021 - 04/2002
3	Amyloid beta-PeptidesIBA 03/2016 - 03/2014
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2014 - 03/2012
3	prolyl-proline (Pro-Pro)IBA 12/2011 - 09/2010
3	arginylarginine (Arg-Arg)IBA 12/2011 - 09/2010
3	arginylprolineIBA 12/2011 - 09/2010
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2010 - 07/2010
2	IronIBA 05/2024 - 09/2023
2	Cadherins (E-Cadherin)IBA 11/2023 - 08/2020
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2023 - 01/2023
2	CarbohydratesIBA 09/2023 - 01/2020
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2023 - 10/2018
2	Angiotensin IIIBA 09/2023 - 12/2021
2	Tranexamic Acid (AMCA)FDA Link 05/2023 - 04/2023

Therapy/Procedure

26	Therapeutics 04/2024 - 09/2002
6	Radiotherapy 03/2024 - 12/2012
6	Drug Therapy (Chemotherapy) 04/2023 - 08/2010
5	Transplantation 02/2023 - 11/2004
4	Immunotherapy 03/2024 - 01/2018
4	Stents 01/2021 - 10/2016
3	Anesthesia 01/2024 - 02/2004
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2021
3	Aftercare (After-Treatment) 09/2023 - 10/2018
3	Ligation 01/2023 - 06/2003
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 12/2020
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2016 - 08/2011
3	Conformal Radiotherapy 12/2014 - 08/2010
2	Length of Stay 01/2024 - 10/2012
2	Topical Administration 05/2023 - 04/2023